by Gabi Schaller | Jan 31, 2022 | News
January 31, 2022, VIENNA, AUSTRIA: Ribbon Biolabs, the DNA synthesis company, today announced the successful close of EUR 18 million in its Series A funding round from a consortium of European and US investors led by Hadean Ventures and with participation from...
